Federal contractor · DOYLESTOWN, PA

FOX CHASE CHEMICAL DIVERSITY CENTER INC.

No contract obligations recorded for FOX CHASE CHEMICAL DIVERSITY CENTER INC. in FY2026. It also received $2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
V6EQM9ABEM89
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 306.5KFY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for FOX CHASE CHEMICAL DIVERSITY CENTER INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

FOX CHASE CHEMICAL DIVERSITY CENTER INC. received $2M in federal assistance in FY2026, on 5 actions (1 new awards), −40% vs FY2025. Its largest program was 93.866 · Aging Research ($1.1M).

Assistance · FY2026
$2M
New awards
1
Actions
5
Since FY2021
$23.6M

Assistance by fiscal year

  1. 4MFY2021
  2. 5.1MFY2022
  3. 5MFY2023
  4. 4.1MFY2024
  5. 3.4MFY2025
  6. 2MFY2026

By type

  1. Grants$2M100%

Top programs

  1. 93.866 · Aging Research$1.1M53%
  2. 93.855 · Allergy and Infectious Diseases Research$958.1K47%

Awarding agencies

  1. National Institutes of Health$2M100%
    Department of Health and Human Services

Largest awards

  1. THERAPEUTICS TARGETING TDP-43 TO TREAT ALZHEIMER'S DISEASE AND RELATED DISORDERS - TDP-43 IS A MIXED PROTEINOPAPTHY IN ALZHEIMER’S DISEASE…$7.4M
    93.866 · Aging Research· National Institutes of Health· Cooperative agreement· Jun 23, 2021 – May 28, 2026· U01AG068823
  2. TRYPANOCIDAL AGENTS THAT KILL MULTIPLE STAGES OF THE TRYPANOSOMA CRUZI LIFE CYCLE - ABSTRACT. CHAGAS DISEASE IS A NEGLECTED TROPICAL…$3.1M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 7, 2023 – Mar 9, 2026· R44AI152788
  3. DEVELOPMENT OF A PEPTIDE-DRUG CONJUGATE FOR TOPICALLY TREATING THE VIRAL SKIN DISEASE MOLLUSCUM CONTAGIOSUM - ABSTRACT MOLLUSCUM…$3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 31, 2024 – Jun 30, 2026· R42AI162385
  4. AI-DRIVEN DISCOVERY OF IN VIVO CHEMICAL PROBES FOR UNDERSTUDIED TARGETS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS…$1.1M
    93.866 · Aging Research· National Institutes of Health· Project grant· Feb 17, 2026 – Feb 17, 2026· R01AG098139
  5. DEVELOPMENT OF HOST- ORIENTED THERAPEUTICS TARGETING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), - THE ULTIMATE GOAL OF…$592.4K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 22, 2022 – Feb 13, 2026· R41AI172464

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

  • Sub-grants: $63.6K (1 subaward)

1 sub-recipient

  1. UNIVERSITY OF SOUTHERN CALIFORNIA$63.6K100%
    LOS ANGELES, CA · 1 subaward

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $415.4K (1 subaward)

1 prime

  1. DUKE UNIVERSITY$415.4K100%
    DURHAM, NC · 1 subaward

By fiscal year

  • FY2021: $1.3M paid out · $411.7K received
  • FY2022: $1.5M paid out · $130.6K received
  • FY2023: $2.6M paid out · $443.3K received
  • FY2024: $2.3M paid out · $994.7K received
  • FY2025: $498K paid out · $655.1K received
  • FY2026: $63.6K paid out · $415.4K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

13 companies · $8.3M reported

  1. TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE$3.6M
    PHILADELPHIA, PA · 6 subawards
  2. RUTGERS, THE STATE UNIVERSITY$809.4K
    NEW BRUNSWICK, NJ · 1 subaward
  3. TEXAS BIOMEDICAL RESEARCH INSTITUTE$717.7K
    SAN ANTONIO, TX · 2 subawards

Primes that pay it

5 companies · $3.1M reported

  1. LOUISIANA STATE UNIVERSITY$1.4M
    SHREVEPORT, LA · 4 subawards
  2. DUKE UNIVERSITY$706K
    DURHAM, NC · 2 subawards
  3. TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE$400.5K
    PHILADELPHIA, PA · 4 subawards

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. MUCOMMUNE LLC$306.2K−100% in FY2026
    DURHAM, NC · 99.9% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. IMMPORT THERAPEUTICS INC$300K
    IRVINE, CA · 98% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. BASE PAIR BIOTECHNOLOGIES INC$300K
    PEARLAND, TX · 98% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.